相关实验视频

Updated: Jun 10, 2025

Author Spotlight: Insights into the Effect of Ischemia Reperfusion on Lung Transplantation
06:45

Author Spotlight: Insights into the Effect of Ischemia Reperfusion on Lung Transplantation

Published on: April 12, 2024

1.3K

血素缓解无菌炎症在缺血-再输液诱导的肺损伤

Tomoyuki Nakagiri1,2, Nadine R Köhler1, Sabina Janciauskiene2,3,4

  • 1Department of Cardiothoracic, Transplantation, and Vascular Surgery, Hannover Medical School, Hannover, Germany.

Frontiers in immunology
|October 21, 2024
PubMed
概括

血素 (Hx) 治疗减少了小鼠模型中的肺炎和肺损伤. 这表明Hx可能是治疗肺部疾病的有希望的疗法,如初级移植功能障碍.

关键词:
这里是他的家园.血液素 (hemopexin) 是一种血液素.缺血-再输血损伤的损伤肺 肺 肺 肺 肺 肺 肺 肺 肺无菌炎症是一种无菌的炎症.

更多相关视频

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury08:27

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury

Published on: May 21, 2018

10.9K
Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy07:05

Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy

Published on: September 27, 2024

413

相关概念视频

Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
4.8K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
154